NOVEL FOOD – EFSA published further Safety Assessments - meyer.science | München | Naturwissenschaftliche Beratung von Firmen der Lebensmittel‑, Kosmetik- und Pharmabranche

Product Development - Health Claims – Crisis Management - Dossiers & Applications for Authorization

Food Contact Materials – Migration Tests – Risk Assessment

Borderline Issues – Authorization & Certification – Benefits Evaluation

Composition of Substances - Labeling - Marketing – Safety Assessment

The European Food Safety Authority (EFSA) published the following opinions concerning novel food evaluations:

Safety of viable embryonated eggs of the whipworm Trichuris suis as a novel food pursuant to Regulation (EU) 2015/2283 [EFSA Journal 2019;17(8):5777]: EFSA concluded that the safety of the Novel Food (NF) has not been established.
Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC [EFSA Journal 2019;17(8):5775]: EFSA concluded that the NF is safe under the proposed conditions of use for the healthy adult population, excluding pregnant and lactating women, and that an intake of the NF up to 230 mg/day is safe for pregnant and lactating women.

The European Food Safety Authority (EFSA) published the following opinions concerning novel food evaluations:

Safety of viable embryonated eggs of the whipworm Trichuris suis as a novel food pursuant to Regulation (EU) 2015/2283 [EFSA Journal 2019;17(8):5777]: EFSA concluded that the safety of the Novel Food (NF) has not been established.
Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC [EFSA Journal 2019;17(8):5775]: EFSA concluded that the NF is safe under the proposed conditions of use for the healthy adult population, excluding pregnant and lactating women, and that an intake of the NF up to 230 mg/day is safe for pregnant and lactating women.